SyntekaBio Extends Largest Shareholder’s Share Pledge to Nov. 30, 2026

• SyntekaBio corrected its disclosure to extend the share collateral period to November 30, 2026, from October 30, 2026.
• The agreement pledges 2,800,000 shares against KRW 2.85 billion in borrowings, with collateral valued at KRW 5.04 billion.
• Full enforcement would reduce the largest shareholder’s stake to 3.13% from 14.67%, potentially triggering a change in the largest shareholder.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SyntekaBio Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030901028), on October 30, 2026, and is solely responsible for the information contained therein.